Neuroplasticity in Auditory Aging_Project 2 Aims 1 and 2
2 other identifiers
interventional
405
1 country
1
Brief Summary
Millions of elderly adults in the USA have age related hearing loss (ARHL), a malady that affects half of adults 60-69 years, and the majority of older adults. This hearing loss not only impacts communication and functional ability, but also is strongly associated with cognitive decline and decreased quality of life. This project aims to develop effective strategies to compensate and reverse this process through a deeper understanding of plasticity and adaptive auditory function, and how to engage it and harness it to remedy ARHL.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 21, 2018
CompletedFirst Submitted
Initial submission to the registry
March 15, 2018
CompletedFirst Posted
Study publicly available on registry
March 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2024
CompletedApril 8, 2025
April 1, 2025
6.3 years
March 15, 2018
April 3, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Improvement in behavioral auditory temporal processing measures (Aim 1)
Decrease in threshold (in msec) for discriminating a comparison pulse train to a standard, decrease in cross-over points (in msec) for trained word contrasts, and increase in rate of speech for 50% correct recognition
completion of study, approximately 30 months
Improvement in recognition of trained stimuli - fast speech (Aim 2)
Increase in speech rate at which listener maintains 50% and 80% correct recognition
completion of study, approximately 24 months
Secondary Outcomes (3)
Change in spectral energy and neural phase locking for trained stimuli (Aim 1)
completion of study, approximately 30 months
Change in phase locking to trained or equivalent stimuli (Aim 2)
completion of study in approximately 24 months
Change in reconstruction accuracy to trained or equivalent stimuli (Aim 2)
completion of study in approximately 24 months
Study Arms (3)
Auditory training: temporal cues
EXPERIMENTALAim 1: Listeners will hear target acoustic stimuli that vary in a temporal (timing/duration) cue for 9, 1-hour training sessions and will receive correct-answer feedback. Aim 2: Listeners will hear sentences that vary in speech rate for 6, 1-hour training sessions and will receive correct-answer feedback.
Auditory training: non-temporal cues
ACTIVE COMPARATORAim 1: Listeners will hear target acoustic stimuli that vary in either stimulus intensity or stimulus frequency during 9, 1-hour training sessions and will receive correct-answer feedback. Aim 2: Listeners will hear speech in varying levels of noise during 6, 1-hour training sessions and will receive correct-answer feedback.
Passive control group (Aims 1 and 2)
NO INTERVENTIONListeners will be evaluated on pre-training and post-training tests, but will receive no training at all.
Interventions
Behavioral training for 6-9 hours in listening to specific characteristics of acoustic signals. Listeners receive correct-answer feedback on each trial.
Eligibility Criteria
You may qualify if:
- native speaker of English
- normal cognitive function as measured on Montreal Cognitive Assessment
- pass screening auditory brainstem response test to make sure they have recordable brainwaves to acoustic stimuli
- age and hearing sensitivity:
- young normal-hearing listeners, 18-35 years, hearing thresholds less than 25 decibels (dB) HL from 250 - 4000 Hz;
- older normal-hearing listeners, 65-85 years, hearing thresholds less than 25 dB HL, from 250-4000 Hz;
- older hearing-impaired listeners, 65-85 years, with mild-to-moderate, high frequency sensorineural hearing loss;
- high school diploma
You may not qualify if:
- absence of conductive hearing loss and middle-ear disease
- no neurological disease
- severe or profound hearing loss
- non-native speaker of English
- cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Maryland, College Parklead
- National Institute on Aging (NIA)collaborator
- National Institutes of Health (NIH)collaborator
Study Sites (1)
University of Maryland
College Park, Maryland, 20742, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sandra Gordon-Salant, Ph.D.
University of Maryland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Examiners who conduct pre, post, and retention tests with participants do not know to which group a participant is assigned (experimental group, active control group, passive control group).
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 15, 2018
First Posted
March 23, 2018
Study Start
February 21, 2018
Primary Completion
May 31, 2024
Study Completion
May 31, 2024
Last Updated
April 8, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Six months after publication until May 31, 2022
- Access Criteria
- The data will be available only to Institutional Review Board-approved colleagues and collaborators under an agreement that provides for: (1) a commitment to using the data only for research purposes and not to inappropriately identify any individual participant; and (2) a commitment to securing the data using appropriate information technology and practices. The PI (Gordon-Salant) and co-PI (Anderson) will review requests for access to the data. Once approved, access will be provided by Prometheus Software, LLC. Prometheus will develop best practices for securely sharing research data with our collaborators and the wider scientific community. Finally, Prometheus will ensure that the project complies with all relevant data distribution agreements and data submission requirements.
The investigators will share the final dataset that includes initial assessment information, behavioral performance pre-training and post-training data, and neurophysiologic data. Any shared dataset(s) will be stripped of protected health information (PHI) before release, and the investigators will make the data and associated documentation available only to IRB-approved colleagues and collaborators under an agreement that provides for: (1) a commitment to using the data only for research purposes and not to inappropriately identify any individual participant; and (2) a commitment to securing the data using appropriate information technology and practices.